Trials / Recruiting
RecruitingNCT07231029
A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
An Open-label Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
An open-label study to evaluate the effect of TS-172 administration on pharmacokinetics in patients with hepatic impairment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-172 | Single oral administration of TS-172 20mg |
Timeline
- Start date
- 2025-12-23
- Primary completion
- 2026-10-26
- Completion
- 2026-10-31
- First posted
- 2025-11-17
- Last updated
- 2026-01-09
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT07231029. Inclusion in this directory is not an endorsement.